Tumor-Infiltrating Lymphocyte Therapy for Melanoma
Tumor-infiltrating lymphocytes (TILs) have demonstrated enduring clinical advantages in trials for advanced-stage melanoma, even when the disease has worsened.
Dr. Abdul Aziz Khan